+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
BioCryst Pharmaceuticals Inc - logo

BioCryst Pharmaceuticals is a biotechnology company that designs and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. BioCryst's core development programs include BCX7353 and additional 2nd generation oral inhibitors of plasma kallikrein for hereditary angioedema; and BCX4430 (GALIDESIVIR), a broad spectrum antiviral for hemorrhagic fevers. The company was founded in 1986 and is headquartered in Durham, North Carolina.

From
Hereditary Angioedema - Pipeline Insight, 2020 - Product Thumbnail Image

Hereditary Angioedema - Pipeline Insight, 2020

  • Clinical Trials
  • September 2020
  • 100 pages
From
From
From
From
From
Global Coronavirus Partnering 2014-2021 - Product Thumbnail Image

Global Coronavirus Partnering 2014-2021

  • Report
  • April 2021
  • 650 pages
From
From
From
From
Loading Indicator
adroll